Answers are grounded in this paper and cite their sources.
Enzyme-responsive granular biomaterials could improve three-dimensional tumor models by coupling matrix remodeling with drug-associated transport. We developed Gel-LLS, a packed matrix of gelatin microgels stabilized by EDC/NHS-mediated amide coupling. Microgels had a mean longest-axis dimension of 98 ± 28 µm and resisted dissolution at 37 °C. After 12 h, a normalized degradation index based on TAMRA-amine fluorescence reached about 25%, 50%, and 100% with 0.1, 0.5, and 1 mg/mL collagenase type IV, respectively. U87 glioblastoma spheroids showed 98 ± 2% viability at 24 h. Over 12 h, normalized dispersion hull area increased from 1.00 to 1.64, radius of gyration from 1.00 to 1.11, and external skeleton index from 2.2 to 5.8, whereas the polyacrylamide reference changed minimally. Collagenase also enabled intact spheroid recovery. With doxorubicin-loaded lipid nanoparticles (DOX-LNPs), 0.1 mg/mL collagenase increased normalized DOX-associated supernatant fluorescence to 23% at 12 h, versus 4% without enzyme, and Hoechst/PI analysis measured 80% cell death. During 24 h dialysis, less than 5% of formulation-associated DOX was recovered in the external medium, with or without 1 mg/mL collagenase IV. Gel-LLS provides an enzyme-responsive in vitro platform for studying U87 spheroid redistribution, recovery, and drug-delivery-associated responses over the investigated time periods.
No takes yet. Share an insight, caveat, or question.
Pepe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: